Last Posted: Aug 31, 2018
- Liquid Biopsy 'Weather Forecast' Can Predict When Tumors Will Return
V Forster, Forbes, August 30, 2018 - A Multicenter Study to Assess EGFR Mutational Status in Plasma: Focus on an Optimized Workflow for Liquid Biopsy in a Clinical Setting.
Sorber Laure et al. Cancers 2018 Aug 10(9) - Molecular profiling of lung cancer specimens and liquid biopsies using MALDI-TOF mass spectrometry.
Bonaparte Eleonora et al. Diagnostic pathology 2018 Jan 13(1) 4 - The Beauty Of 'Small Data' In Medicine, From Measuring Kids To Tumor Mutations
I Kohane, WBUR, August 29, 2018 - Multidisciplinary molecular tumour board: a tool to improve clinical practice and selection accrual for clinical trials in patients with cancer.
Rolfo Christian et al. ESMO open 2018 3(5) e000398 - The diagnostic role of plasma circulating precursors of miRNA-944 and miRNA-3662 for non-small cell lung cancer detection.
Powrózek Tomasz et al. Pathology, research and practice 2017 Nov 213(11) 1384-1387 - The NETest: The Clinical Utility of Multigene Blood Analysis in the Diagnosis and Management of Neuroendocrine Tumors.
Modlin Irvin M et al. Endocrinology and metabolism clinics of North America 2018 Sep 47(3) 485-504 - A digital RNA signature of Circulating Tumor Cells predicting early therapeutic response in localized and metastatic breast cancer
TT Kwan et al, Cancer Discovery, April 13, 2018 - Circulating Cell Free DNA: Applications in the Clinical and Toxicology Setting
NIEHS, Workshop, September 24-25, 2018 - Liquid biopsy approach in the management of prostate cancer.
Riaz Irbaz Bin et al. Translational research : the journal of laboratory and clinical medicine 2018 May
.jpg)
No hay comentarios:
Publicar un comentario